CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Legal Officer sold 1,635 shares at $12.84 ($20,993)
- 4 Planned sale See Remarks sold 58,333 shares at an average $12.92 ($753,937)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Planned sale Chief Legal Officer sold 1,635 shares at $13.65 ($22,318)
- 4 Planned sale See Remarks sold 58,333 shares at $13.90 ($811,004)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer sold 584 shares at $14.00 ($8,176)
- 4 Planned sale See Remarks sold 69,076 shares at an average $15.75 ($1,088,273)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer sold 3,270 shares at an average $12.10 ($39,567)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale See Remarks sold 26,842 shares at $10.23 ($274,596)
- 144 Insider Sale of Securities
- 4 Planned sale See Remarks sold 12,415 shares at $10.05 ($124,722)
- 144 Insider Sale of Securities
Page 1 of 22 · 440 filings